138 related articles for article (PubMed ID: 16704985)
1. Associations of genetic variants in the estrogen receptor coactivators PPARGC1A, PPARGC1B and EP300 with familial breast cancer.
Wirtenberger M; Tchatchou S; Hemminki K; Schmutzhard J; Sutter C; Schmutzler RK; Meindl A; Wappenschmidt B; Kiechle M; Arnold N; Weber BH; Niederacher D; Bartram CR; Burwinkel B
Carcinogenesis; 2006 Nov; 27(11):2201-8. PubMed ID: 16704985
[TBL] [Abstract][Full Text] [Related]
2. PPARGC1A rs3736265 G>A polymorphism is associated with decreased risk of type 2 diabetes mellitus and fasting plasma glucose level.
Zhu L; Huang Q; Xie Z; Kang M; Ding H; Chen B; Chen Y; Liu C; Wang Y; Tang W
Oncotarget; 2017 Jun; 8(23):37308-37320. PubMed ID: 28418876
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants of PPAR-gamma coactivator 1B augment NLRP3-mediated inflammation in gouty arthritis.
Chang WC; Jan Wu YJ; Chung WH; Lee YS; Chin SW; Chen TJ; Chang YS; Chen DY; Hung SI
Rheumatology (Oxford); 2017 Mar; 56(3):457-466. PubMed ID: 28394398
[TBL] [Abstract][Full Text] [Related]
4. Association between PPARγ, PPARGC1A, and PPARGC1B genetic variants and susceptibility of gastric cancer in an Eastern Chinese population.
Chen B; Wang Y; Tang W; Chen Y; Liu C; Kang M; Xie J
BMC Med Genomics; 2022 Dec; 15(1):274. PubMed ID: 36587194
[TBL] [Abstract][Full Text] [Related]
5. Association of peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PPARGC1A) gene polymorphisms and type 2 diabetes mellitus: a meta-analysis.
Yang Y; Mo X; Chen S; Lu X; Gu D
Diabetes Metab Res Rev; 2011 Feb; 27(2):177-84. PubMed ID: 21294239
[TBL] [Abstract][Full Text] [Related]
6. Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer.
Li Y; Li Y; Wedrén S; Li G; Charn TH; Desai KV; Bonnard C; Czene K; Humphreys K; Darabi H; Einarsdóttir K; Heikkinen T; Aittomäki K; Blomqvist C; Chia KS; Nevanlinna H; Hall P; Liu ET; Liu J
Breast Cancer Res; 2011 Jan; 13(1):R10. PubMed ID: 21269472
[TBL] [Abstract][Full Text] [Related]
7. Associations of genetic variants in the transcriptional coactivators EP300 and PCAF with hepatocellular carcinoma.
Akil A; Ezzikouri S; El Feydi AE; Benazzouz M; Afifi R; Diagne AG; Benjouad A; Dejean A; Pineau P; Benjelloun S
Cancer Epidemiol; 2012 Oct; 36(5):e300-5. PubMed ID: 22709982
[TBL] [Abstract][Full Text] [Related]
8. PPARGC1A variation associated with DNA damage, diabetes, and cardiovascular diseases: the Boston Puerto Rican Health Study.
Lai CQ; Tucker KL; Parnell LD; Adiconis X; García-Bailo B; Griffith J; Meydani M; Ordovás JM
Diabetes; 2008 Apr; 57(4):809-16. PubMed ID: 18162502
[TBL] [Abstract][Full Text] [Related]
9. Assessment of
Chen Z; Wang Y; Wang J; Kang M; Tang W; Chen S
DNA Cell Biol; 2020 Sep; 39(9):1521-1531. PubMed ID: 32721231
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of obesity associated with the variant allele of the PPARGC1A Gly482Ser polymorphism in physically inactive elderly men.
Ridderstråle M; Johansson LE; Rastam L; Lindblad U
Diabetologia; 2006 Mar; 49(3):496-500. PubMed ID: 16474966
[TBL] [Abstract][Full Text] [Related]
11. The functional genetic variant Ile646Val located in the kinase binding domain of the A-kinase anchoring protein 10 is associated with familial breast cancer.
Wirtenberger M; Schmutzhard J; Hemminki K; Meindl A; Sutter C; Schmutzler RK; Wappenschmidt B; Kiechle M; Arnold N; Weber BH; Niederacher D; Bartram CR; Burwinkel B
Carcinogenesis; 2007 Feb; 28(2):423-6. PubMed ID: 16956908
[TBL] [Abstract][Full Text] [Related]
12. PPARγ and PPARGC1B polymorphisms modify the association between phthalate metabolites and breast cancer risk.
Martínez-Nava GA; Burguete-García AI; López-Carrillo L; Hernández-Ramírez RU; Madrid-Marina V; Cebrián ME
Biomarkers; 2013 Sep; 18(6):493-501. PubMed ID: 23866026
[TBL] [Abstract][Full Text] [Related]
13. Haplotypes of PPARGC1A are associated with glucose tolerance, body mass index and insulin sensitivity in offspring of patients with type 2 diabetes.
Pihlajamäki J; Kinnunen M; Ruotsalainen E; Salmenniemi U; Vauhkonen I; Kuulasmaa T; Kainulainen S; Laakso M
Diabetologia; 2005 Jul; 48(7):1331-4. PubMed ID: 15912394
[TBL] [Abstract][Full Text] [Related]
14. Interaction of Werner and Bloom syndrome genes with p53 in familial breast cancer.
Wirtenberger M; Frank B; Hemminki K; Klaes R; Schmutzler RK; Wappenschmidt B; Meindl A; Kiechle M; Arnold N; Weber BH; Niederacher D; Bartram CR; Burwinkel B
Carcinogenesis; 2006 Aug; 27(8):1655-60. PubMed ID: 16501249
[TBL] [Abstract][Full Text] [Related]
15. Common variation at PPARGC1A/B and change in body composition and metabolic traits following preventive interventions: the Diabetes Prevention Program.
Franks PW; Christophi CA; Jablonski KA; Billings LK; Delahanty LM; Horton ES; Knowler WC; Florez JC;
Diabetologia; 2014 Mar; 57(3):485-90. PubMed ID: 24317794
[TBL] [Abstract][Full Text] [Related]
16. The estrogen receptor alpha C975G variant in familial and sporadic breast cancer: a case-control study.
Skoglund J; Margolin S; Zhou XL; Maguire P; Werelius B; Lindblom A
Anticancer Res; 2006; 26(4B):3077-81. PubMed ID: 16886637
[TBL] [Abstract][Full Text] [Related]
17. A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.
Zhang N; Huo Q; Wang X; Chen X; Long L; Guan X; Jiang L; Ma T; Hu W; Yang Q
Gene; 2014 Feb; 535(2):170-6. PubMed ID: 24316488
[TBL] [Abstract][Full Text] [Related]
18. DNA sequence variants in PPARGC1A, a gene encoding a coactivator of the ω-3 LCPUFA sensing PPAR-RXR transcription complex, are associated with NV AMD and AMD-associated loci in genes of complement and VEGF signaling pathways.
SanGiovanni JP; Chen J; Sapieha P; Aderman CM; Stahl A; Clemons TE; Chew EY; Smith LE
PLoS One; 2013; 8(1):e53155. PubMed ID: 23335958
[TBL] [Abstract][Full Text] [Related]
19. [Association study between PPARGC1A Thr394Thr/ Gly482Ser polymorphisms and type 2 diabetes].
Su Y; Peng SB; Li ZQ; Huang QY
Yi Chuan; 2008 Mar; 30(3):304-8. PubMed ID: 18331997
[TBL] [Abstract][Full Text] [Related]
20. Polyglutamine repeat length in the AIB1 gene modifies breast cancer susceptibility in BRCA1 carriers.
Kadouri L; Kote-Jarai Z; Easton DF; Hubert A; Hamoudi R; Glaser B; Abeliovich D; Peretz T; Eeles RA
Int J Cancer; 2004 Jan; 108(3):399-403. PubMed ID: 14648706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
